Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference

Gastric, esophageal and gastro-esophageal junction cancers are associated with inferior outcomes. For early-stage disease, perioperative chemotherapy or chemoradiation followed by surgery is the standard treatment. For most patients with advanced upper gastrointestinal tract cancers, platinum-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Karen, Lim, Howard, Ravi, Deepti, Ahmed, Shahida, Brunet, Bryan, Davies, Janine, Doll, Corinne, Dueck, Dorie-Anna, Gordon, Vallerie, Hebbard, Pamela, Kim, Christina A., Le, Duc, Lee-Ying, Richard, McGhie, John Paul, Park, Jason, Renouf, Daniel J., Schellenberg, Devin, Wong, Ralph P. W., Zaidi, Adnan, Ahmed, Shahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139288/
https://www.ncbi.nlm.nih.gov/pubmed/35621647
http://dx.doi.org/10.3390/curroncol29050257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139288/
https://www.ncbi.nlm.nih.gov/pubmed/35621647
http://dx.doi.org/10.3390/curroncol29050257

Ejemplares similares